HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Goulbourne, C, Vaux, D
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Portland Press 2010

Gelijkaardige items

The structural basis of ZMPSTE24-dependent laminopathies
door: Quigley, A, et al.
Gepubliceerd in: (2013)

The structural basis of ZMPSTE24-dependent laminopathies.
door: Quigley, A, et al.
Gepubliceerd in: (2013)

Prelamin A and ZMPSTE24 in premature and physiological aging
door: Howard J. Worman, et al.
Gepubliceerd in: (2023-12-01)

ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
door: Moritz Messner, et al.
Gepubliceerd in: (2020-08-01)

Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
door: Jemima Barrowman, et al.
Gepubliceerd in: (2012-01-01)

Acquired and Inherited Lipodystrophies
Gepubliceerd in: (2004-06-01)

Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy
door: Aline Francielle Mota Segatto, et al.
Gepubliceerd in: (2011-08-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
door: N. Sunil Kumar, et al.
Gepubliceerd in: (2015-07-01)

Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity
door: Robert J. Stott-Marshall, et al.
Gepubliceerd in: (2022-02-01)

运用二代测序技术产前诊断ZMPSTE24基因突变
door: 麦明琴, et al.
Gepubliceerd in: (2017-01-01)

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
door: William S. Hambright, et al.
Gepubliceerd in: (2023-01-01)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
door: Ayako Nagayama, et al.
Gepubliceerd in: (2021-05-01)

Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24-deficient mice
door: Jie Zhang, et al.
Gepubliceerd in: (2024-05-01)

HIV-1 protease as a target for antiretroviral therapy
door: Windsor, Ian William.
Gepubliceerd in: (2019)

Acquired lipodystrophy following use of pembrolizumab
door: Maya Weitzen, et al.
Gepubliceerd in: (2024-12-01)

Acquired partial lipodystrophy associated with varicella
door: Zafer Kurugöl, et al.
Gepubliceerd in: (2009-12-01)

The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa
door: Honoré Kalombayi Tshamala, et al.
Gepubliceerd in: (2019-01-01)

Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
door: Pere Domingo, et al.
Gepubliceerd in: (2010-11-01)

Influence of the duration of antiretroviral use on insulin resistance among people living with HIV with lipodystrophy
door: Thiago Rodrigues Faria Vitorazzi, et al.
Gepubliceerd in: (2018-12-01)

Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24.
door: Kaitlin M Wood, et al.
Gepubliceerd in: (2020-01-01)

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B
door: Kamsi O. Odinammadu, et al.
Gepubliceerd in: (2023-12-01)

Lipodystrophy syndrome in HIV /
door: Wanke, Christine A., et al.
Gepubliceerd in: (2003)

The Place of protease inhibitors in antiretroviral treatment
door: S.B. Tenore, et al.

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
door: Bwakura-Dangarembizi, M, et al.
Gepubliceerd in: (2015)

Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24
door: Mehmood, S, et al.
Gepubliceerd in: (2016)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
door: Spear, ED, et al.
Gepubliceerd in: (2018)

Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation
door: Jinlong Suo, et al.
Gepubliceerd in: (2023-05-01)

A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy
door: Damien Galant, et al.
Gepubliceerd in: (2016-04-01)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
door: Eric D. Spear, et al.
Gepubliceerd in: (2018-07-01)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch
door: Simeon Eche, et al.
Gepubliceerd in: (2021-03-01)

Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.
door: Cordula Frohoff, et al.
Gepubliceerd in: (2011-02-01)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
door: Musiime, V, et al.
Gepubliceerd in: (2014)

Barraquer–Simons Lipodystrophy Syndrome in an Otherwise Normal Child: A Rare Case of Acquired Partial Lipodystrophy
door: Kananbala Sahu, et al.
Gepubliceerd in: (2021-01-01)

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen
door: Mohammed Mitha, et al.
Gepubliceerd in: (2010-11-01)

Overview of HIV-related lipodystrophy
door: T Marie Rossouw, et al.
Gepubliceerd in: (2013-02-01)

Hiv-associated lipodystrophy and exercise
door: E. Mutimura, et al.
Gepubliceerd in: (2006-02-01)

Restrictive Dermopathy Due to ZMPSTE24 Mutation: A Case Report with a Novel Finding of Corpus Callosum Agenesis
door: Minu Jose Chiramel, et al.
Gepubliceerd in: (2024-01-01)

Deficiency in ZMPSTE24 and resulting farnesyl–prelamin A accumulation only modestly affect mouse adipose tissue stores[S]
door: Patrick J. Heizer, et al.
Gepubliceerd in: (2020-03-01)

Inherited and acquired lipodystrophies: molecular-genetic and autoimmune mechanisms
door: Ekaterina L. Sorkina, et al.
Gepubliceerd in: (2018-04-01)

Acquired partial lipodystrophy: An atypical presentation with therapeutic challenge
door: Komali Garlapati, et al.
Gepubliceerd in: (2015-01-01)